This Week’s Top Cannabis Developments: A Closer Look
Mississippi’s Advertising Ban Challenge Declined by US Supreme Court
The US Supreme Court has opted not to hear a challenge against Mississippi’s restrictions on medical cannabis advertising. This decision stems from the efforts of Clarence Cocroft, proprietor of Tru Source Medical Cannabis, who contends that the ban has significantly hindered his business. Nestled in an industrial park with minimal foot traffic, Cocroft has struggled to attract customers without the ability to advertise openly. He remarked that he hoped for a Supreme Court hearing to ensure his business would be regarded on par with other lawful enterprises in Mississippi.
Cocroft argued that the advertising ban infringes on his First Amendment rights, highlighting the ongoing legal challenges faced by cannabis businesses striving to operate under the current legislative frameworks. This case underlines the broader national conversation about cannabis legislation and its impacts on industry stakeholders.
Cannabis Reform Needed, Urges Cannabis Council of Canada
Following a shift in Canada’s political landscape with Mark Carney now at the helm as Prime Minister, the Cannabis Council of Canada is urging the new administration to address critical gaps in the country’s legal cannabis industry. Paul McCarthy, the Council’s president, has called for a comprehensive review of existing policies that have been perceived as inadequate since legalization in 2018.
McCarthy emphasized the need for parity, stating that the cannabis industry should receive the same governmental support as other economic sectors. He urged the government to assist the tens of thousands of Canadians employed within the industry, reiterating Canada’s position as a global leader in the cannabis market.
Exploring Cannabis Research in Healer’s Latest Webinar
Dr. Dustin Sulak, founder of Healer, spearheaded a recent webinar focusing on the latest cannabis research concerning wide-ranging health issues. Topics covered included emerging research on cannabis applications for conditions such as hypermobility-associated chronic pain, eczema, Parkinson’s disease, and inflammatory bowel disease.
These discussions reflect ongoing scientific efforts to harness cannabis’s therapeutic potential, providing valuable insights for practitioners, researchers, and patients looking to cannabis as a treatment option.
THC’s Impact on Driving Skills Examined
A team of researchers in Australia has published a study that explores how THC affects the cognitive skills necessary for safe driving among medical cannabis users. Analyzing the effects of both orally ingested oil and vaporized cannabis flower, the study compared neuropsychological performance with and without THC consumption.
This research, appearing in the “Drug and Alcohol Review,” underscores the importance of understanding cannabis’s acute impacts on user capabilities, particularly in populations accustomed to its long-term use.
Ohio Senate Passes Intoxicating Hemp Products Bill
In recent legislative advancements, the Ohio Senate has unanimously approved Senate Bill 86. This bill restricts the sale of intoxicating hemp products to state-licensed adult-use cannabis dispensaries, barring sales from locations like smoke shops and convenience stores.
The bill enacts a 10% tax on these products, sets a minimum purchasing age of 21, and imposes stringent testing and labeling requirements. These measures aim to regulate the sale and consumption of intoxicating hemp products, ensuring consumer safety and compliance with state laws.
#CannabisNews #MedicalCannabis #CannabisResearch #CannabisPolicy #HempRegulation